Hajime Kuboshima
Direttore/Membro del Consiglio presso MEDIBIC GROUP
Profilo
Hajime Kuboshima is currently the Director at MediBIC Group, Director at Site Quality Co., Ltd., President & Representative Director at MediBIC Pharma, President & Representative Director at MediBIC KK, and President & Representative Director at Animal Stemcell KK.
He completed his undergraduate degree at the London School of Economics & Political Science in 1999.
Posizioni attive di Hajime Kuboshima
Società | Posizione | Inizio |
---|---|---|
MEDIBIC GROUP | Direttore/Membro del Consiglio | - |
MediBIC KK
MediBIC KK Miscellaneous Commercial ServicesCommercial Services Part of MediBIC Group, MediBIC KK develops genomic medicines. The company is based in Tokyo, Japan. The Japanese company was founded by Yasuhiro Hashimoto. | Presidente | 01/03/2015 |
Animal Stemcell KK
Animal Stemcell KK BiotechnologyHealth Technology Part of MediBIC Group, Animal Stemcell KK engages in research and development, and production of animal stem cells and regenerative medicine. The company is based in Koganei, Japan. Animal Stemcell KK was acquired by MediBIC Group from Resort & Medical Co., Ltd. on October 08, 2013 for $3.02 million. | Presidente | 01/04/2013 |
Site Quality Co., Ltd.
Site Quality Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Site Quality Co., Ltd. provides consulting services to medical institutions. It offers informed consent acquisition assistance, patient schedule administration, hospital data collection management, time monitoring, case report form preparation support, document creation assistance, and clinical research coordination. The company was founded in November 2003 and is headquartered in Hachioji, Japan. | Direttore/Membro del Consiglio | - |
MediBIC Pharma | Presidente | - |
Formazione di Hajime Kuboshima
London School of Economics & Political Science | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
MediBIC Group
MediBIC Group Miscellaneous Commercial ServicesCommercial Services MediBIC Group is a holding company which engages in the biotechnology industry that specializes in pharmacogenomics (PGx). It engages in analysis and reporting service on healthcare and drug development; information processing, services and consulting in biotech field; computer system design and development; drug & diagnostic product development; and business consulting services. The firm’s services also include sample banking and management service, GLP-compliant Gene Profiling Service, genetic testing service, licensing, cell culture systems and consumable sale. The company was founded on February 17, 2000 and is headquartered in Tokyo, Japan. | Commercial Services |
Site Quality Co., Ltd.
Site Quality Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Site Quality Co., Ltd. provides consulting services to medical institutions. It offers informed consent acquisition assistance, patient schedule administration, hospital data collection management, time monitoring, case report form preparation support, document creation assistance, and clinical research coordination. The company was founded in November 2003 and is headquartered in Hachioji, Japan. | Commercial Services |
MediBIC Pharma | |
MediBIC KK
MediBIC KK Miscellaneous Commercial ServicesCommercial Services Part of MediBIC Group, MediBIC KK develops genomic medicines. The company is based in Tokyo, Japan. The Japanese company was founded by Yasuhiro Hashimoto. | Commercial Services |
Animal Stemcell KK
Animal Stemcell KK BiotechnologyHealth Technology Part of MediBIC Group, Animal Stemcell KK engages in research and development, and production of animal stem cells and regenerative medicine. The company is based in Koganei, Japan. Animal Stemcell KK was acquired by MediBIC Group from Resort & Medical Co., Ltd. on October 08, 2013 for $3.02 million. | Health Technology |
- Borsa valori
- Insiders
- Hajime Kuboshima